CD4 and influenza: This study involved a cohort of patients who had recovered from COVID-19 because we had previously demonstrated that these patients had high levels of CD4+ memory T cells specific to SARS-CoV-2- and H1N1 influenza, whereas COVID-19 naïve subjects had influenza-specific but not SARS-CoV-2-specific responses [13].